Literature DB >> 26388154

Precision cancer medicine: where to target?

Qiang Yu1, Jian Ding1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26388154      PMCID： PMC4648173          DOI： 10.1038/aps.2015.93

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN： 1671-4083            Impact factor:   6.150


× No keyword cloud information.
  18 in total

Review 1.  Classical chemotherapy: mechanisms, toxicities and the therapeutic window.

Authors:  Vikas Malhotra; Michael C Perry
Journal:  Cancer Biol Ther       Date:  2003 Jul-Aug       Impact factor: 4.742

Review 2.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

Review 3.  The role of autophagy in cancer development and response to therapy.

Authors:  Yasuko Kondo; Takao Kanzawa; Raymond Sawaya; Seiji Kondo
Journal:  Nat Rev Cancer       Date:  2005-09       Impact factor: 60.716

Review 4.  Alternative splicing as a biomarker and potential target for drug discovery.

Authors:  Kai-qin Le; Bellur S Prabhakar; Wan-jin Hong; Liang-cheng Li
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 5.  Genome-wide analysis of microRNA and mRNA expression signatures in cancer.

Authors:  Ming-hui Li; Sheng-bo Fu; Hua-sheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

Review 6.  Toward rapamycin analog (rapalog)-based precision cancer therapy.

Authors:  Ling-hua Meng; X F Steven Zheng
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

Review 7.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

Review 8.  Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms.

Authors:  Eran Elinav; Roni Nowarski; Christoph A Thaiss; Bo Hu; Chengcheng Jin; Richard A Flavell
Journal:  Nat Rev Cancer       Date:  2013-11       Impact factor: 69.800

Review 9.  Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.

Authors:  Cheng Sun; Hao-yu Sun; Wei-hua Xiao; Cai Zhang; Zhi-gang Tian
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 10.  Novel endogenous angiogenesis inhibitors and their therapeutic potential.

Authors:  Nithya Rao; Yu Fei Lee; Ruowen Ge
Journal:  Acta Pharmacol Sin       Date:  2015-09-14       Impact factor: 6.150
View more
  2 in total

Review 1.  Improved Protein Toxin Delivery Based on ATTEMPTS Systems.

Authors:  Yingzhi Chen; Meng Zhang; Kyoung Ah Min; Huiyuan Wang; Meong Cheol Shin; Feng Li; Victor C Yang; Yongzhuo Huang
Journal:  Curr Drug Targets       Date:  2018-02-19       Impact factor: 3.465

Review 2.  Antibody-Drug Conjugates: The New Frontier of Chemotherapy.

Authors:  Sara Ponziani; Giulia Di Vittorio; Giuseppina Pitari; Anna Maria Cimini; Matteo Ardini; Roberta Gentile; Stefano Iacobelli; Gianluca Sala; Emily Capone; David J Flavell; Rodolfo Ippoliti; Francesco Giansanti
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.